Skip to main content

Main menu

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Subscribers
    • Advertisers
    • Editorial Board
    • Special Issues
  • Journal Metrics
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics

User menu

  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Anticancer Research
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics
  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Anticancer Research

Advanced Search

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Subscribers
    • Advertisers
    • Editorial Board
    • Special Issues
  • Journal Metrics
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Visit us on Facebook
  • Follow us on Linkedin
Research ArticleExperimental Studies

Cyclooxygenase-2 Gene Induction Causes CDDP Resistance in Colon Cancer Cell Line, HCT-15

YOSHIRO SAIKAWA, TSUDOI SUGIURA, FUMIKI TORIUMI, TETSURO KUBOTA, KAZUHIRO SUGANUMA, SOICHIRO ISSHIKI, YOSHIHIDE OTANI, KOICHIRO KUMAI and MASAKI KITAJIMA
Anticancer Research September 2004, 24 (5A) 2723-2728;
YOSHIRO SAIKAWA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
TSUDOI SUGIURA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
FUMIKI TORIUMI
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
TETSURO KUBOTA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
KAZUHIRO SUGANUMA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
SOICHIRO ISSHIKI
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
YOSHIHIDE OTANI
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
KOICHIRO KUMAI
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
MASAKI KITAJIMA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Info & Metrics
  • PDF
Loading

Article Information

vol. 24 no. 5A 2723-2728
PMID 
15517878

Published By 
International Institute of Anticancer Research
Print ISSN 
0250-7005
Online ISSN 
1791-7530
History 
  • Received March 12, 2004
  • Accepted June 21, 2004
  • Published online September 1, 2004.

Copyright & Usage 
Copyright© 2004 International Institute of Anticancer Research (Dr. John G. Delinassios), All rights reserved

Author Information

  1. YOSHIRO SAIKAWA1,
  2. TSUDOI SUGIURA1,
  3. FUMIKI TORIUMI1,
  4. TETSURO KUBOTA1,
  5. KAZUHIRO SUGANUMA1,
  6. SOICHIRO ISSHIKI2,
  7. YOSHIHIDE OTANI1,
  8. KOICHIRO KUMAI1 and
  9. MASAKI KITAJIMA1
  1. 1Department of Surgery, School of Medicine, Keio University, Shinjuku-ku, Tokyo 160-8582
  2. 2Department of Surgery, Kawasaki City Hospital, Kawasaki-ku, Kawasaki, Kanagawa 210-0013, Japan
  1. Correspondence to: Yoshiro Saikawa, Department of Surgery, School of Medicine, Keio University, 35 Shinanomachi, Shinjukuku, Tokyo 160-8582, Japan. Tel: + 81 3 3353 1211 ext. 62334, Fax: + 81 3 3355 4707, e-mail: saiky{at}sc.itc.keio.ac.jp

Statistics from Altmetric.com

Cited By...

  • 38 Citations
  • Citations
  • Google Scholar

This article has not yet been cited by articles in journals that are participating in Crossref Cited-by Linking.

PreviousNext
Back to top

In this issue

Anticancer Research
Vol. 24, Issue 5A
September-October 2004
  • Table of Contents
  • Table of Contents (PDF)
  • Index by author
  • Front Matter (PDF)
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Anticancer Research.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Cyclooxygenase-2 Gene Induction Causes CDDP Resistance in Colon Cancer Cell Line, HCT-15
(Your Name) has sent you a message from Anticancer Research
(Your Name) thought you would like to see the Anticancer Research web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
7 + 1 =
Solve this simple math problem and enter the result. E.g. for 1+3, enter 4.
Citation Tools
Cyclooxygenase-2 Gene Induction Causes CDDP Resistance in Colon Cancer Cell Line, HCT-15
YOSHIRO SAIKAWA, TSUDOI SUGIURA, FUMIKI TORIUMI, TETSURO KUBOTA, KAZUHIRO SUGANUMA, SOICHIRO ISSHIKI, YOSHIHIDE OTANI, KOICHIRO KUMAI, MASAKI KITAJIMA
Anticancer Research Sep 2004, 24 (5A) 2723-2728;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Reprints and Permissions
Share
Cyclooxygenase-2 Gene Induction Causes CDDP Resistance in Colon Cancer Cell Line, HCT-15
YOSHIRO SAIKAWA, TSUDOI SUGIURA, FUMIKI TORIUMI, TETSURO KUBOTA, KAZUHIRO SUGANUMA, SOICHIRO ISSHIKI, YOSHIHIDE OTANI, KOICHIRO KUMAI, MASAKI KITAJIMA
Anticancer Research Sep 2004, 24 (5A) 2723-2728;
Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
  • Info & Metrics
  • PDF

Related Articles

Cited By...

  • Etodolac Improves 5-FU Sensitivity of Head and Neck Cancer Cells through Inhibition of Thymidylate Synthase
  • Resistance to chemotherapy and hormone therapy in endometrial cancer
  • Google Scholar

More in this TOC Section

  • 6-O-Carboxypropyl-α-Tocotrienol Enhances the Anticancer Effects of Bortezomib Without Suppressing NRF1 and NRF3 in Colorectal Cancer Cells
  • Imbalance Between CD44 and STAT3 Enhances Spheroid Viability and Impairs Pembrolizumab Response in Urothelial Cancer
  • Imipramine Targets Apoptosis, Metastasis, and EGFR/SRC-mediated EMT in Oral Cancer Cells
Show more Experimental Studies
Anticancer Research

© 2026 Anticancer Research

Powered by HighWire